Emdogain Research: Emdogain in Regenerative Periodontal Therapy. A Review of The Literature
Emdogain Research: Emdogain in Regenerative Periodontal Therapy. A Review of The Literature
Emdogain Research: Emdogain in Regenerative Periodontal Therapy. A Review of The Literature
The goal of regenerative periodontal therapy is the reconstitution of the lost periodontal structures (i.e. the new
formation of root cementum, periodontal ligament and alveolar bone). Results from basic research have pointed to
the important role of the enamel matrix protein derivative (EMD) in the periodontal wound healing. Histological
results from animal and human studies have shown that treatment with EMD promotes periodontal regeneration.
Moreover, clinical studies have indicated that treatment with EMD positively influences periodontal wound healing
in humans. The goal of the current overview is to present, based on the existing evidence, the clinical indications for
regenerative therapy with EMD. Surgical periodontal treatment of deep intrabony defects with EMD promotes
periodontal regeneration. Surgical periodontal therapy of deep intrabony defects with EMD may lead to significantly
higher improvements of the clinical parameters than open flap debridement alone. The results obtained following
treatment with EMD are comparable to those following treatment with GTR and can be maintained over a longer
period. Treatment of intrabony defects with a combination of EMD + GTR does not seem to additionally improve
the results compared to treatment with EMD alone or GTR alone. The combination of EMD and some types of bone
grafts/bone substitutes may result in certain improvements in the soft and hard tissue parameters compared to
treatment with EMD alone. Treatment of recession-type defects with coronally repositioned flaps and EMD may
promote formation of cementum, periodontal ligament and bone, and may significantly increase the width of the
keratinized tissue. Application of EMD seems to provide better long-term results than coronally repositioned flaps
alone. Application of EMD may enhance periodontal regeneration in mandibular Class II furcations. The clinical
results are comparable to those obtained following GTR.
Perioscopy aided MIS using Enamal Matrix Proteins compared to conventional surgery
Harrell, SK,T.G. Wilson- Journal of Periodontology
2005, Vol. 76, No. 3, Pages 380-384
(doi:10.1902/jop.2005.76.3.380)
Clinical Trials:
Minimally invasive surgical technique and enamel matrix derivative in intra-bony defects. I: Clinical
outcomes and morbidity.
Accademia Toscana di Ricerca Odontostomatologica, Via Carlo Botta 16, Florence, Italy.
studiocortellini@cortellini.191.it
AIMS: This case cohort study was designed to evaluate the clinical performance and the intra-operative and post-
operative morbidity of the minimally invasive surgical technique (MIST) associated with the application of an
enamel matrix derivative (EMD) in the treatment of isolated deep intra-bony defects. MATERIAL AND
METHODS: Forty deep isolated intra-bony defects in 40 patients were surgically accessed with the MIST. This
technique was designed to limit the mesio-distal flap extension and the corono-apical flap reflection in order to
reduce the surgical trauma and increase flap stability. The incision of the defect-associated papilla was performed
according to the principles of the papilla preservation techniques. EMD was applied on the debrided and dried root
surfaces. Stable primary closure of the flaps was obtained with modified internal mattress sutures. Surgery was
performed with the aid of an operating microscope and microsurgical instruments. Clinical outcomes were collected
at baseline and at 1 year. Intra-operative and post-operative morbidity was evaluated with questionnaires.
RESULTS: The 1-year clinical attachment gain was 4.9+/-1.7 mm (p<0.0001 compared with baseline). This
corresponded to a 77.6+/-21.9% resolution of the defect. Residual probing pocket depths were 3+/-0.6 mm. A
minimal increase of 0.4+/-0.7 mm in gingival recession between baseline and 1 year was recorded. No patients
experienced intra-operative pain, while only 14 reported a very moderate perception of the hardship of the surgical
procedure [7+/-12 visual-analogue scale (VAS) units, on average]. Primary closure was obtained in all treated sites.
At the 1-week follow-up visit, 38 sites (95%) were still closed. Only 12 subjects reported moderate post-operative
pain (VAS 19+/-10) that lasted for 26+/-17 h. CONCLUSIONS: These data indicate that the minimally invasive
surgical technique, in combination with EMD, can be successfully applied in the treatment of isolated deep intra-
bony defects, resulting in excellent clinical outcomes with very limited intra- and post-operative morbidity.
The goal of regenerative periodontal therapy is the reconstitution of the lost periodontal structures (i. e. the new
formation of root cementum, periodontal ligament and alveolar bone). Results from basic research have pointed to
the important role of an enamel matrix protein derivative (EMD) in periodontal wound healing. Histological results
from experiments in animals and from human case reports have shown that treatment with EMD promotes
periodontal regeneration. Moreover, clinical studies have indicated that treatment with EMD positively influences
periodontal wound healing in humans.
Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular
bone defects.
Full Abstract
BACKGROUND: This prospective case series report aimed at analyzing the long-term (5 years) stability of
clinical attachment level (CAL) gains following regenerative therapy with the use of enamel matrix proteins in
intrabony defects. METHODS: A total of 114 consecutively treated periodontal patients (mean age: 55.8
years) were initially included. Each subject exhibited at least one deep proximal intrabony defect with the
inclusion criteria of 1) probing depth (PD)>or=5 mm, 2) clinical attachment loss>or=6 mm, and 3)
radiographic evidence of a >or=3-mm intrabony component. A total of 146 defects met the criteria for
inclusion. At least 6 months after the completion of an initial phase of mechanical infection control, a baseline
examination was performed to characterize the experimental site. Reconstructive therapy with the use of
enamel matrix proteins was subsequently performed. Experimental sites were reexamined 1 and 5 years after
reconstructive surgery. Primary efficacy variables were considered to be changes in PD, CAL, soft tissue
recession (REC), and radiographic defect depth (RDD). Stepwise regression analysis was employed for
evaluation of predicting factors of CAL change between the 1- and 5-year reexaminations. RESULTS: A total of
82 patients (102 defects) were included in the analysis. One year following the regenerative surgery, a mean
CAL gain of 4.3 mm (P<0.001), a mean PD reduction of 4.9 mm (P<0.001), and a mean increase in REC of
0.6 mm (P<0.001) were recorded. At the 5-year follow-up, a further mean PD reduction of 0.3 mm (P>0.05),
CAL gain of 1.1 mm (P<0.01), and reduction in recession of 0.8 mm (P<0.01) had taken place. Radiographs
revealed that the bone defect had been reduced in depth with an average of 2.9 mm at 1 year (P<0.001). No
statistically significant alteration in defect depth was observed between 1 and 5 years of follow-up. The
stepwise regression analysis identified the degree of REC and residual PD at 1 year as significant predictors of
CAL change between 1 and 5 years. CONCLUSION: Results demonstrated long-term (5 years) stability of CAL
gains following regenerative therapy with the use of enamel matrix proteins in intrabony defects.
Abstract
Journal of Periodontology
2009, Vol. 80, No. 9, Pages 1534-1540 , DOI 10.1902/jop.2009.090160
(doi:10.1902/jop.2009.090160)